| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/15/1998 | EP0835127A1 Compositions and methods using myelin-associated glycoprotein (mag) and inhibitors thereof |
| 04/15/1998 | EP0835126A1 Compositions and formulations for producing analgesia and for inhibiting progression of neuropathic pain disorders |
| 04/15/1998 | EP0835125A1 Cd4-derived peptides that inhibit immune responses |
| 04/15/1998 | EP0835122A1 Latent transcripts and promoters of cytomegalovirus |
| 04/15/1998 | EP0835104A1 Use of stat 5 sh2 domain specific compounds to enhance erythropoiesis |
| 04/15/1998 | EP0804065A4 Transgenic plants and plant cells with enhanced pathogen resistance and related methods |
| 04/15/1998 | EP0753152B1 Solid phase immunoassay to detect inhibitors of proteolytic enzymes |
| 04/15/1998 | EP0699305B1 Methods, agents and kits for detection of organophosphorus compounds |
| 04/15/1998 | EP0696200A4 Encapsulation of nucleic acids with conjugates that facilitate and target cellular uptake and gene expression |
| 04/15/1998 | EP0650367A4 Blocking intercellular interactions with cd43 chimeric molecules. |
| 04/15/1998 | EP0640130B1 Chimeric multivalent protein analogues and methods of use thereof |
| 04/15/1998 | EP0515434B1 Method for treating intestinal diseases |
| 04/15/1998 | EP0460052B1 Il-1 biological activity inhibitors |
| 04/15/1998 | CN1179180A RAGE tumer rejection antigens |
| 04/15/1998 | CN1179163A Gclq receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies |
| 04/15/1998 | CN1179106A Recombinant human alpha-fetoprotein and uses thereof |
| 04/15/1998 | CN1178797A Oligopeptide derivative containing alpha, gamma-diaminobutanoic acid |
| 04/15/1998 | CN1038035C Preparing method for polyethylene protein conjugates |
| 04/15/1998 | CN1038034C Rapid synthesis and screening of peptide mimetics |
| 04/15/1998 | CA2218456A1 Purified stat proteins and methods of purifying thereof |
| 04/14/1998 | US5739409 Endogenously sweetened transgenic plant products |
| 04/14/1998 | US5739407 Genetic engineering dna encodes a polypeptide |
| 04/14/1998 | US5739307 Cell growth factors |
| 04/14/1998 | US5739306 gC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies |
| 04/14/1998 | US5739293 Contacting impure protein fraction with cation-exchange medium to bind impurities but not glycoprotein, binding glycoprotein to anion-exchange mediu, eluting |
| 04/14/1998 | US5739292 HCMV/HSV fusion glycoproteins |
| 04/14/1998 | US5739291 Glutamate receptor antibodies |
| 04/14/1998 | US5739290 Monoclonal antibody against an interferon-induced human protein in pure form |
| 04/14/1998 | US5739289 Produced by specified hybridoma |
| 04/14/1998 | US5739288 Fibrin sealant compositions |
| 04/14/1998 | US5739286 Mineralized intact collagen fibers; precipitated crystalline calcium phosphate |
| 04/14/1998 | US5739284 Compositions corresponding to a high-affinity glutamate transporter molecule and methods for making and using same |
| 04/14/1998 | US5739283 Prevention of invasive pulmonary aspergillosis with serine proteinase inhibitors |
| 04/14/1998 | US5739282 Amino acid sequence and dna |
| 04/14/1998 | US5739281 Subjecting proteins to a time sequence of multiple denaturing-renaturing cycles |
| 04/14/1998 | US5739277 Altered polypeptides with increased half-life |
| 04/14/1998 | US5739276 Conotoxin peptides |
| 04/14/1998 | US5739274 Comprising polypeptide linked to phospholipid; produces delayed increase in blood pressure, increase in extracellular calcium uptake by vascular smooth muscle |
| 04/14/1998 | US5739273 Conjugated bacteriorhodopsin for drug delivery |
| 04/14/1998 | US5739272 Procedure for obtaining carbocalcitonin |
| 04/14/1998 | US5739118 Compositions and methods for delivery of genetic material |
| 04/14/1998 | US5739107 Morphogen treatment of gastrointestinal ulcers |
| 04/14/1998 | US5739106 Appetite regulating compositions |
| 04/14/1998 | US5739103 Mutants; antiinflammatory agents; anticholesterol agents; cardiovascular disorders; antiarthritic agents |
| 04/14/1998 | US5739102 Wound healing |
| 04/14/1998 | US5739101 Administering an anticoagulants |
| 04/14/1998 | US5739082 Method of improving the yield of herbicide-resistant crop plants |
| 04/14/1998 | US5739032 Isolated nucleic acid encodes a glycoprotein for treating leukocyte adhesion deficiency |
| 04/14/1998 | US5739029 Vectors for expression of G protein coupled receptors in yeast |
| 04/14/1998 | US5739027 MTS1E1β gene |
| 04/14/1998 | US5739026 DNA expression systems based on alphaviruses |
| 04/14/1998 | US5739012 Stable activator from genetically engineered cells |
| 04/14/1998 | US5739011 DNA for the production of multimeric hemoglobins |
| 04/14/1998 | US5739010 Human transcription factor |
| 04/14/1998 | US5739009 Adipocyte-specific differentiation-related protein |
| 04/14/1998 | US5739008 DNA encoding a protein comprising calmodulin-and actin-binding human caldesmon peptide fragment |
| 04/14/1998 | US5739007 Hybrid GAL10/pgk yeast promoter |
| 04/14/1998 | US5739002 Providing reaction mixture comprising ns3 protease and substrate, adding candidate compound comprising fragment of hepatitis c virus ns4a protein, measuring protease activity to determine whether increase has occurred |
| 04/14/1998 | US5738999 Mediate inhibition of transmitter release at selected glutamatergic synapses |
| 04/14/1998 | US5738990 Sequence-directed DNA-binding molecules compositions and methods |
| 04/14/1998 | US5738985 Screening for potential antiviral agent by determining whether a potential antiviral agent interacts with a virus or cellular component which allows or prevents preferential translation of a virus rna |
| 04/14/1998 | US5738984 Kits and methods of detection using cellulose binding domain fusion proteins |
| 04/14/1998 | US5738878 Purification, isolation by eluting with aqueous methanol solution; liquid chromatography |
| 04/14/1998 | US5738854 Genetic engineered mutant dna; veterinary medicine |
| 04/14/1998 | US5738853 Human papillomaviruses and mutants which code for proteins |
| 04/14/1998 | US5738852 Methods of enhancing antigen-specific T cell responses |
| 04/14/1998 | US5738849 Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them |
| 04/14/1998 | US5738848 Immunosuppressive compounds and method of preparing same |
| 04/14/1998 | US5738847 Anti-VH3-15 reagents and methods for their use |
| 04/14/1998 | US5738846 Conjugating interferon to polymer strand having one or both ends activated by carbamate-or amide-forming groups |
| 04/14/1998 | US5738845 Human interferon τ proteins and methods of use |
| 04/14/1998 | US5738844 Polypeptides |
| 04/14/1998 | US5738838 Metal ion-binding domains are labeled with medically useful metal ions for lung imaging |
| 04/14/1998 | US5738784 Device for separating a blood component from blood or plasma |
| 04/14/1998 | CA2116691C Plasma fraction purification |
| 04/14/1998 | CA2034947C Molecules with antibody combining sites that catalyze hydrolysis reactions |
| 04/09/1998 | WO1998014605A1 Renilla luciferase and green fluorescent protein fusion genes |
| 04/09/1998 | WO1998014593A2 Human telomerase catalytic subunit |
| 04/09/1998 | WO1998014592A2 Telomerase reverse transcriptase |
| 04/09/1998 | WO1998014591A1 Novel expression vectors for production of foreign proteins as soluble forms |
| 04/09/1998 | WO1998014587A1 Inhibition of hiv replication using soluble tat peptide analogs |
| 04/09/1998 | WO1998014586A1 A polynucleotide herpes virus vaccine |
| 04/09/1998 | WO1998014585A1 Nucleocapsid gene of seoul virus r22, recombinant plasmid, transformed e. coli and diagnostic agent and vaccine for haemorrhagic fever with renal syndrome |
| 04/09/1998 | WO1998014584A2 Compositions and methods for the prevention and diagnosis of human granulocytic ehrlichiosis |
| 04/09/1998 | WO1998014583A2 Method for producing recombinants intended for use in a complete malaria antigene gp190/msp1 |
| 04/09/1998 | WO1998014582A1 Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (mpif-1), monocyte colony inhibitory factor (m-cif), and macrophage inhibitory factor-4 (mip-4) |
| 04/09/1998 | WO1998014581A1 Mammalian chemokines |
| 04/09/1998 | WO1998014579A1 Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders |
| 04/09/1998 | WO1998014578A1 Biological insect control agents expressing insect-specific mite toxin genes, methods and compositions |
| 04/09/1998 | WO1998014577A3 Nucleotide and protein sequence of mammastatin and methods of use |
| 04/09/1998 | WO1998014577A2 Nucleotide and protein sequence of mammastatin and methods of use |
| 04/09/1998 | WO1998014576A2 Secreted proteins and polynucleotides encoding them |
| 04/09/1998 | WO1998014575A1 Secreted proteins and polynucleotides encoding them________________________________________________________________________________________________________________________________________________ |
| 04/09/1998 | WO1998014574A1 Elongin a and c functional domains |
| 04/09/1998 | WO1998014573A1 Mcp-4 and mcp-5: novel chemokines |
| 04/09/1998 | WO1998014572A1 Novel human phospholemman-like protein |
| 04/09/1998 | WO1998014571A1 Human sulfonylurea receptor surh |
| 04/09/1998 | WO1998014570A1 NOVEL ATPase INHIBITOR |
| 04/09/1998 | WO1998014569A1 Leukocyte-specific protein and gene, and methods of use thereof |
| 04/09/1998 | WO1998014568A1 Human growth gene and short stature gene region |